Clinical Trials Update: June 1, 2009

Bladder Disorders Seizure Disorders Non-Small Cell Lung Cancer Postherpetic Neuralgia (Pain from Shingles) Type 2 Diabetes ADHD (Attention Deficit Hyperactivity Disorder)

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:

Bladder Disorders

If you are an adult with overactive bladder symptoms of urinary frequency and urgency, you may qualify for this study.

The research site is in Charlotte, N.C.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=445.

-----

Seizure Disorders

If you have seizures, you may qualify for this study.

The research site is in Lexington, Ky.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=138.

-----

Non-Small Cell Lung Cancer

If you are an adult with non-small cell lung cancer and have not been treated for the condition (surgery, radiation and/or chemotherapy), you may qualify for this study.

The research site is in Bronx, N.Y.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=683.

-----

Postherpetic Neuralgia (Pain from Shingles)

This study is to assess the effectiveness of a drug taken once daily with the evening meal compared to placebo in reducing the average daily pain score in people with pain from shingles.

The research site is in Indianapolis, Ind.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/postherpetic_neuralgia.aspx.

-----

Type 2 Diabetes

This study will evaluate the safety and effectiveness of an investigational medication for type 2 diabetes. You may qualify if you are aged 18 to 85, have been diagnosed with type 2 diabetes for at least four months, and are taking metformin to treat diabetes.

The research site is in Albuquerque, N.M.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.

-----

ADHD (Attention Deficit Hyperactivity Disorder)

This study will evaluate an investigational medication to supplement ADHD treatment in children ages 6-17.

The research site is in Miami, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/adhd.aspx.

-----

Copyright 2009 CenterWatch and ClinicalConnection.com. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com